BlackRock »

Oncternal Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $299k 39k 7.60
2024-03-31 $354k 39k 9.00